Wayland Group Corp MRRCF

The McKesson Deal is too Big to Ignore

[truestar2]

Obviously the financials were expected due to heavy legals from the financing, the NanoLeaf acquisition, McKesson, etc..  I don't think the market can ignore 3000 Pharmacies and the fact that Maricann may be one of the only LPs to be able to sell and maintain a client base at high margins as most others will have to sell to the provinces or retailers at low wholesale pricing.  If you can average 6 dollars a gram vs 3 dollars a gram and your all in cost including Opex is 2 dollars a gram your in a whole different league of profitability.  I believe Germany will be similar and only those able to maintain their medical clients who are also a much stickier client when referred by their pharmacist and doctor will be highly profitable long term